833 results on '"Borch-Johnsen, K."'
Search Results
2. The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status
3. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study
4. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark
5. The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes
6. Cumulative glycaemia as measured by lens fluorometry: association with retinopathy in type 2 diabetes
7. HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study
8. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
9. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study
10. Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people
11. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study
12. Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study
13. Diagnosing diabetes—time for a change?
14. A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads
15. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?
16. Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction
17. The Danish National Diabetes Register: trends in incidence, prevalence and mortality
18. Relative validity of a food frequency questionnaire used in the Inter99 study
19. A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit
20. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
21. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action
22. Polymorphisms in AHI1 are not associated with type 2 diabetes or related phenotypes in Danes: non-replication of a genome-wide association result
23. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark
24. Studies of the associations between functional β2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects
25. The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study
26. Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark
27. Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects
28. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects
29. Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance
30. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group
31. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes
32. The common T60N polymorphism of the lymphotoxin-α gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome
33. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes
34. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy
35. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms
36. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia
37. Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion
38. Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity
39. Large-scale studies of the HphI insulin gene variable-number-of-tandem-repeats polymorphism in relation to Type 2 diabetes mellitus and insulin release
40. The FOXC2 -512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects
41. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications
42. A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The LIFE Study
43. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
44. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians
45. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts
46. Risk scores for predicting type 2 diabetes: using the optimal tool
47. The rise and fall of the metabolic syndrome
48. O3-3.2 Low vitamin D status and risk of type 2 diabetes: a prospective cohort study
49. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
50. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.